PharmiWeb.com - Global Pharma News & Resources
25-Jan-2021

Siemens Healthineers AG: Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) and Art. 2 para. 3 of the Delegated Regulation (EU) No. 2016/1052

DGAP-News: Siemens Healthineers AG / Key word(s): Share Buyback
25.01.2021 / 17:16
The issuer is solely responsible for the content of this announcement.

Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) and Art. 2 para. 3 of the Delegated Regulation (EU) No. 2016/1052

Share buyback - 8th Interim Reporting

In the time period from and including 18 January 2021 until and including 22 January 2021, a number of 131,964 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 03 October 2020, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 07 October 2020.

Shares were bought back as follows:

Day of purchase Aggregated volume of shares Weighted average price
01/20/2021 27,411 44.4576
01/21/2021 55,082 44.6668
01/22/2021 49,471 44.5061
 

The transactions are published in a detailed form on the website of Siemens Healthineers AG (www.corporate.siemens-healthineers.com/investor-relations).

The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 07 October 2020 until and including 22 January 2021 amounts to 3,487,877 shares.

The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA).

Munich, 25 January 2021

Siemens Healthineers AG
The Managing Board



25.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Siemens Healthineers AG
Henkestr. 127
91052 Erlangen
Germany
Phone: +49 800 188 188 5
Fax: +49 9131 844552
E-mail: contact@healthcare.siemens.com
Internet: https://www.corporate.siemens-healthineers.com
ISIN: DE000SHL1006
WKN: SHL100
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1163093

 
End of News DGAP News Service

Editor Details

Last Updated: 25-Jan-2021